News from american diabetes association A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 17, 2019, 16:00 ET American Diabetes Association® Celebrates 70 Years of Fun, Educational Camps for Children

For 70 years, the American Diabetes Association (ADA) has hosted summer camps for children and teens with type 1 diabetes. In 2019 nearly 7,000...


Jun 11, 2019, 14:45 ET Oral Semaglutide Reduces Occurrence of Major Cardiac Events in People with Type 2 Diabetes With High Cardiovascular Risk

Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk, according...


Jun 11, 2019, 12:54 ET Safety of Linagliptin for Adults with Type 2 Diabetes Who Have High Risk of Cardiovascular and/or Renal Disease Examined in CARMELINA

Linagliptin, when added to usual diabetes care in people with type 2 diabetes (T2D) with increased risk of cardiovascular (CV) and/or renal disease,...


Jun 11, 2019, 12:30 ET Canagliflozin Shown to Improve Cardiovascular and Renal Outcomes in People with Type 2 Diabetes and Kidney Disease

For people with type 2 diabetes (T2D) and chronic kidney disease (CKD), canagliflozin, an oral, sodium-glucose co-transporter-2 (SGLT2) inhibitor,...


Jun 10, 2019, 21:30 ET Linagliptin and Glimepiride Have Comparable Cardiovascular Safety Effects in Type 2 Diabetes at High Cardiovascular Risk

The diabetes medications glimepiride and linagliptin had similar impacts on cardiovascular morbidity and mortality for a median period of 6.3 years,...


Jun 10, 2019, 14:20 ET Dulaglutide is Safe and Effective for People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease

In an analysis of the AWARD-7 study, people with type 2 diabetes (T2D) and moderate-to-severe chronic kidney disease (CKD) who took 1.5 mg of...


Jun 10, 2019, 13:00 ET Access to Continuous Glucose Monitors in Pediatric Diabetes Populations Improves Glycemic Control, Reduces Hypoglycemia and Improves Satisfaction with Diabetes Care and Technology Use

Diabetes requires management 24 hours a day, seven days a week, 365 days of the year and presents numerous daily challenges, particularly for...


Jun 09, 2019, 22:04 ET Dapagliflozin Reduces Progression of Kidney Disease and Renal Death in People with Type 2 Diabetes

The first sub-analysis of renal data from the Dapagliflozin Effect on Cardiovascular Events Thrombolysis In Myocardial Infarction (DECLARE-TIMI 58)...


Jun 09, 2019, 21:30 ET Type 1 Diabetes May Affect Brain Development, Beginning in Early Childhood

Children with early-onset type 1 diabetes (T1D) and poor glycemic control have slower growth of areas in the brain associated with mild cognitive...


Jun 09, 2019, 21:30 ET Dulaglutide Reduces Cardiovascular Disease in People with Type 2 Diabetes

The Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) trial has found dulaglutide, an injectable, glucagon-like peptide-1 ...


Jun 09, 2019, 16:30 ET Two RISE Clinical Trials in Youth and Adults with Impaired Glucose Tolerance or Newly Diagnosed Type 2 Diabetes Reveal Surprising Differences in Beta-Cell (β-cell) Function During and After Treatment

In a study measuring Beta-cell (β-cell) function in adults with impaired glucose tolerance (IGT) or newly diagnosed type 2 diabetes (T2D),...


Jun 09, 2019, 16:00 ET Consistent Use of Diabetes Technology Across Multiple Environments Benefits Youth with Diabetes

In recent years, diabetes technology has evolved at a rapid pace, and the use of insulin pumps and continuous glucose monitoring (CGM) systems has...


Jun 09, 2019, 13:00 ET Delayed Onset of Type 2 Diabetes by Six Years or More Significantly Reduces Risk of Cardiovascular Disease and Microvascular Disease

People with impaired glucose tolerance (IGT) may significantly lower their risk of cardiovascular disease (CVD) and microvascular disease by delaying ...


Jun 09, 2019, 13:00 ET Teplizumab Delays Clinical Diagnosis of Type 1 Diabetes an Average of Two Years, According to Study Presented at ADA's Scientific Sessions

The Teplizumab Prevention Trial has given validity to the concept that immune therapy can delay the diagnosis of type 1 diabetes (T1D), according to...


Jun 08, 2019, 21:00 ET Weight Loss from Low-Calorie Diet, Followed by Different Weight Management Programs, Provide Comparable Delays to Progression of Type 2 Diabetes

In a comparison of two different diet and two different weight management programs, results of the international PREVIEW intervention study found a...


Jun 08, 2019, 18:45 ET The iLet Bionic Pancreas Increased Time in Range for Adults with Type 1 Diabetes

The iLet bionic pancreas (BP)1 significantly increased the percentage of time adults with type 1 diabetes (T1D) had glucose levels between 70–180...


Jun 08, 2019, 18:45 ET Researchers Find Accelerating Rates of Severe Complications in Young Adults with Youth-Onset Type 2 Diabetes

By continuing to follow the cohort from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study sponsored by the National...


Jun 08, 2019, 13:00 ET High Blood Pressure and Elevated Glucose Levels Present Comparable Risk for Young Adults with Type 1 Diabetes to Develop Heart Disease

High blood pressure and high glucose levels present a similar threat in young adults with type 1 diabetes (T1D) for developing heart disease, with...


Jun 08, 2019, 13:00 ET Insulin-Producing Beta Cells Are Not Irreversibly Lost in Early Type 2 Diabetes

Pancreatic beta cells that do not produce sufficient insulin in people with type 2 diabetes (T2D) are not permanently damaged during the early stages ...


Jun 08, 2019, 13:00 ET New Recommendations for Time-in-Range Targets During Continuous Glucose Monitoring Presented Today at the ADA's Scientific Sessions

Evidence-based guidelines for Continuous Glucose Monitoring (CGM) have been determined by an international panel of diabetes experts striving for...


Jun 07, 2019, 15:30 ET Vitamin D Supplements Do Not Significantly Reduce Risk of Developing Type 2 Diabetes, According to Research Presented Today at the ADA's Scientific Sessions

New research shows that daily oral vitamin D supplementation does not effectively reduce the risk of type 2 diabetes among vitamin D-sufficient...


May 03, 2019, 13:00 ET Stephen O'Rahilly, MD, Named American Diabetes Association's® 2019 Banting Medal Recipient for Scientific Achievement

The American Diabetes Association® (ADA) will present the 2019 Banting Medal for Scientific Achievement, the ADA's highest honor, to Stephen...


Apr 30, 2019, 13:00 ET American Diabetes Association® Announces Recipients of Four 2019 Professional Interest Group Awards

The American Diabetes Association (ADA) is proud to announce the recipients of the ADA's four 2019 Professional Interest Group Awards. Individually...


Apr 30, 2019, 13:00 ET American Diabetes Association® Announces Eight Recipients of 2019 National Scientific and Health Care Achievement Awards

The American Diabetes Association (ADA) is proud to announce the recipients of the ADA's 2019 National Scientific and Health Care Achievement Awards. ...


Apr 18, 2019, 13:00 ET New Consensus Report Recommends Individualized Eating Plan to Meet Each Person's Goals, Life Circumstances and Health Status

Personalized nutrition plans, nutrition for optimal weight management, and the prevention and management of diabetes complications including...